[go: up one dir, main page]

PL1613169T3 - Kompozycje i sposoby formulacji dojelitowych preparatów zawierających kwas sialowy - Google Patents

Kompozycje i sposoby formulacji dojelitowych preparatów zawierających kwas sialowy

Info

Publication number
PL1613169T3
PL1613169T3 PL04759684T PL04759684T PL1613169T3 PL 1613169 T3 PL1613169 T3 PL 1613169T3 PL 04759684 T PL04759684 T PL 04759684T PL 04759684 T PL04759684 T PL 04759684T PL 1613169 T3 PL1613169 T3 PL 1613169T3
Authority
PL
Poland
Prior art keywords
formulation
compositions
methods
sialic acid
formulas containing
Prior art date
Application number
PL04759684T
Other languages
English (en)
Inventor
Robert J Mcmahon
Mary Frances Locniskar
Steven Charles Rumsey
Joshua C Anthony
Ratchapong Wungtanagorn
Original Assignee
Mjn Us Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mjn Us Holdings Llc filed Critical Mjn Us Holdings Llc
Publication of PL1613169T3 publication Critical patent/PL1613169T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/16—Agglomerating or granulating milk powder; Making instant milk powder; Products obtained thereby
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/1307—Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Pediatric Medicine (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
PL04759684T 2003-04-14 2004-03-19 Kompozycje i sposoby formulacji dojelitowych preparatów zawierających kwas sialowy PL1613169T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/413,508 US7867541B2 (en) 2003-04-14 2003-04-14 Compositions and methods of formulation for enteral formulas containing sialic acid
EP04759684A EP1613169B1 (en) 2003-04-14 2004-03-19 Compositions and methods of formulation for enteral formulas containing sialic acid
PCT/US2004/008451 WO2004093557A1 (en) 2003-04-14 2004-03-19 Compositions and methods of formulation for enteral formulas containing sialic acid

Publications (1)

Publication Number Publication Date
PL1613169T3 true PL1613169T3 (pl) 2010-11-30

Family

ID=33131416

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04759684T PL1613169T3 (pl) 2003-04-14 2004-03-19 Kompozycje i sposoby formulacji dojelitowych preparatów zawierających kwas sialowy

Country Status (21)

Country Link
US (1) US7867541B2 (pl)
EP (1) EP1613169B1 (pl)
KR (1) KR101087332B1 (pl)
CN (1) CN100515216C (pl)
AR (1) AR043846A1 (pl)
AT (1) ATE469560T1 (pl)
BR (1) BRPI0409309B1 (pl)
CA (1) CA2522091C (pl)
CL (1) CL2004000803A1 (pl)
DE (1) DE602004027476D1 (pl)
DK (1) DK1613169T3 (pl)
EC (1) ECSP056101A (pl)
ES (1) ES2346533T3 (pl)
MX (1) MXPA05010806A (pl)
MY (1) MY154371A (pl)
NO (1) NO330441B1 (pl)
PL (1) PL1613169T3 (pl)
PT (1) PT1613169E (pl)
RU (1) RU2361408C2 (pl)
TW (1) TWI369183B (pl)
WO (1) WO2004093557A1 (pl)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0951842B1 (en) * 1999-01-20 2002-12-04 N.V. Nutricia Infant formula
CA2431399C (fr) * 2000-12-13 2009-04-28 Institut D'optique Theorique Et Appliquee Procede de caracterisation d'une surface, et dispositif pour sa mise en oeuvre
US20100268658A1 (en) * 2001-05-14 2010-10-21 Prolacta Bioscience Method for collecting, testing and distributing milk
US7951410B2 (en) 2003-04-14 2011-05-31 Mead Johnson Nutrition Company Enteral compositions containing caseinoglycomacropeptide having an enhanced concentration of sialic acid
DE102004040452A1 (de) * 2004-08-20 2006-02-23 N.V. Nutricia Peptidgemisch
JP2008515455A (ja) * 2004-10-12 2008-05-15 フォンテラ コ−オペレイティブ グループ リミティド ベータ−セラム乳製品、中性脂肪除去及び／又は極性脂質濃縮乳製品、及び当該製品の製造方法
US20060247153A1 (en) 2005-04-29 2006-11-02 Mcmahon Robert J Method of improving learning and memory in mammals
US20060246146A1 (en) * 2005-04-29 2006-11-02 Mcmahon Robert J Method of increasing the salivary sialic acid content in a mammal
HUE031206T2 (en) 2005-05-23 2017-06-28 Massachusetts Inst Technology Formulations and methods of application containing PUFA
CA2623483A1 (en) 2005-09-20 2007-03-29 Prolacta Bioscience, Inc. A method for testing milk
US7829126B2 (en) * 2005-10-26 2010-11-09 Abbott Laboratories Infant formulas containing docosahexaenoic acid and lutein
AU2006310880B2 (en) * 2005-11-04 2012-06-28 Arla Foods Amba A concentrate derived from a milk product enriched in naturally occurring sialyllactose and a process for preparation thereof
US20100292168A1 (en) * 2005-11-30 2010-11-18 Katry Inversiones, S.L. Protein Mixture and Use Thereof in the Preparation of a Product that is Intended for Oral or Enteral Administration
ES2366034T3 (es) * 2005-12-23 2011-10-14 N.V. Nutricia Composición que comprende ácidos grasos poliinsaturados, proteínas, manganeso y/o molibdeno y nucleósidos/nucleótidos para el tratamiento de la demencia.
US20080003330A1 (en) * 2006-06-30 2008-01-03 Ricardo Rueda Infant formulas for early brain development
ES2894973T3 (es) * 2006-11-29 2022-02-16 Prolacta Bioscience Inc Composiciones de leche materna y métodos de preparación y uso de las mismas
ES2588527T3 (es) * 2006-12-08 2016-11-03 Prolacta Bioscience, Inc. Composiciones de lípidos humanos y procedimientos de preparación y utilización de los mismos
US20100196539A1 (en) * 2007-06-25 2010-08-05 Albertus Alard Van Dijk Novel prebiotics
BRPI0816993A2 (pt) * 2007-09-17 2014-10-07 Nutricia Nv Uso de uma composição, e, composição nutricional
CN101902918A (zh) * 2007-10-19 2010-12-01 方塔拉合作集团有限公司 保持或增加成长或认知发育的方法
EP2096115A1 (en) * 2008-02-26 2009-09-02 Nestec S.A. Oligosaccharide ingredient
KR101116864B1 (ko) * 2008-08-01 2012-02-29 주식회사 베네비오 고지혈증, 지방간 또는 비만의 예방 또는 치료용 조성물
ES2378854T3 (es) 2008-11-10 2012-04-18 Nestec S.A. Bacterias que producen ácido siálico
CA2745099C (en) 2008-12-02 2017-11-07 Prolacta Bioscience, Inc. Human milk permeate compositions and methods of making and using same
US8293264B2 (en) * 2009-05-11 2012-10-23 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
KR101158472B1 (ko) * 2009-11-05 2012-06-20 주식회사 베네비오 알코올에 유발된 간질환의 예방 또는 치료용 조성물
CN102946728B (zh) * 2010-03-12 2015-09-23 帝斯曼知识产权资产管理有限公司 产妇唾液酸补充
WO2011121151A1 (es) * 2010-03-31 2011-10-06 Vegenat, S.A. Suplemento alimenticio funcional especialmente destinado para la nutrición, prevención y mejora en casos de alteraciones neurológicas, neurodegenerativas o trastornos cognitivos
US20130136800A1 (en) * 2010-03-31 2013-05-30 Vegenat, S.A. Enteral Or Oral Food Product Intended, In Particular, For nutrition And For The Prevention And Improvement Of Neurological Alterations, Neurodegenerative Alterations or Cognitive Disorders
MY192208A (en) 2010-12-31 2022-08-08 Abbott Lab Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
US9539269B2 (en) 2010-12-31 2017-01-10 Abbott Laboratories Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
MY165628A (en) 2010-12-31 2018-04-18 Abbott Lab Human milk oligosaccharides for modulating inflammation
MY166946A (en) 2010-12-31 2018-07-25 Abbott Lab Methods of using human milk oligosaccharides for improving airway respiratory health
SG10201707519PA (en) 2010-12-31 2017-10-30 Abbott Lab Neutral human milk oligosaccharides to promote growth of beneficial bacteria
MY180910A (en) 2010-12-31 2020-12-11 Abbott Lab Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
CN103501638A (zh) 2010-12-31 2014-01-08 雅培制药有限公司 包含人乳低聚糖和核苷酸的营养型组合物以及其治疗和/或预防肠病毒感染的用途
CN103347405A (zh) * 2011-02-10 2013-10-09 雀巢产品技术援助有限公司 使用人乳中发现的寡糖的组合调节双歧杆菌属的生长
EP2730646B2 (en) 2011-06-30 2020-01-22 Chr. Hansen A/S Drying lactic acid bacteria and new compositions
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
DK2734210T3 (en) 2011-07-22 2018-01-22 Abbott Lab GALACTOOLIGOSACCHARIDES FOR THE PREVENTION OF DAMAGE TO AND / OR PROMOTION OF HEALING OF THE MAVE GAS CHANNEL
ES2655019T3 (es) 2011-08-03 2018-02-16 Prolacta Bioscience, Inc. Microfiltración de leche humana para reducir la contaminación bacteriana
US10639319B2 (en) 2011-08-29 2020-05-05 Abbott Laboratories Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
US20140179782A1 (en) * 2011-10-14 2014-06-26 Mead Johnson Nutrition Company Neurogenesis screening method and uses thereof
UA113419C2 (xx) 2011-12-14 2017-01-25 Емульгований харчовий продукт із вмістом молочного білка
US20140179775A1 (en) * 2012-02-29 2014-06-26 Mead Johnson Nutrition Company Neurogenesis screening method and uses thereof
US9351978B2 (en) * 2012-02-29 2016-05-31 Mead Johnson Nutrition Company Neurogenesis screening method and uses thereof
WO2013138157A1 (en) 2012-03-14 2013-09-19 Abbott Laboratories Nutritional compositions including rrr -alpha tocopherol and polyunsaturated fatty acids
SE536599C3 (sv) 2012-04-10 2017-01-10 Hero Ag Näringssammansättning med lågt kalori- och lågt proteininnehåll
CA2903703C (en) 2013-03-13 2018-01-09 Abbott Laboratories Infant nutritional product with rrr alpha-tocopherol
BR112015020568A2 (pt) * 2013-03-13 2017-07-18 Abbott Lab composição para melhorar o desenvolvimento cognitivo, cerebral e/ou do snc do recém-nascido e método para o uso da mesma
US11122813B2 (en) 2013-03-13 2021-09-21 Prolacta Bioscience, Inc. High fat human milk products
CN103478251B (zh) * 2013-07-23 2015-03-25 东北农业大学 一种含唾液酸婴儿配方奶粉的制备方法
CN104187742A (zh) * 2014-07-09 2014-12-10 上海育生堂科技有限公司 一种用于促进青少年儿童成长和改善大脑发育的食用组合物
EP3197295B1 (en) 2014-09-25 2019-03-06 Nestec S.A. Infant formula system with adaptive levels of human milk oligosaccharides (hmos)
WO2016145628A1 (en) * 2015-03-18 2016-09-22 Nestec S.A. Composition comprising siallyllactose for use in enhancing learning skills and memory function
US10525016B2 (en) 2015-06-03 2020-01-07 Mead Johnson Nutrition Company Nutritional compositions containing an elevated level of inositol and uses thereof
US20170006897A1 (en) 2015-07-10 2017-01-12 Mead Johnson Nutrition Company Nutritional compositions and methods for promoting cognitive development
US10582714B2 (en) 2015-07-10 2020-03-10 Mead Johnson Nutrition Company Nutritional compositions and methods for promoting cognitive development
US10034937B2 (en) 2015-12-04 2018-07-31 Mead Johnson Nutrition Company Synergistic nutritional compositions and uses thereof
US11478011B2 (en) * 2015-12-14 2022-10-25 Societe Des Produits Nestle S.A. Nutritional compositions and infant formula for promoting de novo myealination
EP4523542A3 (en) 2015-12-30 2025-05-14 Prolacta Bioscience, Inc. Human milk products useful in pre- and post-operative care
CN106615146A (zh) * 2016-09-01 2017-05-10 西安银桥乳业（集团）有限公司 一种添加组合益生元的婴幼儿配方奶粉及其制备方法
US20180160714A1 (en) 2016-12-12 2018-06-14 Mead Johnson Nutrition Company Nutritional compositions containing butyrate and uses thereof
US20180161292A1 (en) 2016-12-12 2018-06-14 Mead Johnson Nutrition Company Nutritional compositions containing butyrate and uses thereof
US20180168215A1 (en) 2016-12-21 2018-06-21 Mead Johnson Nutrition Company Nutritional compositions containing inositol and uses thereof
US20180332881A1 (en) 2017-05-17 2018-11-22 Mead Johnson Nutrition Company Preterm infant formula containing butyrate and uses thereof
CN107467667B (zh) * 2017-07-17 2018-06-26 北京亦贝安生物医药科技有限公司 一种含有两种不饱和脂肪酸和唾液酸的复方制剂
EP3473644A1 (en) * 2017-10-17 2019-04-24 Jennewein Biotechnologie GmbH Fermentative production of n-acetylneuraminic acid
US20190208807A1 (en) 2018-01-05 2019-07-11 Mead Johnson Nutrition Company Nutritional compositions containing milk-derived peptides and uses thereof
GB2573538B (en) 2018-05-09 2023-01-04 Mjn Us Holdings Llc Pediatric nutritional compositions and methods for infants delivered by C-section
KR20220066904A (ko) 2019-09-24 2022-05-24 프롤랙타 바이오사이언스, 인코포레이티드 염증 및 면역 질환의 치료용 조성물 및 방법
CN111011522A (zh) * 2020-02-27 2020-04-17 青岛索康食品有限公司 一种提高免疫力的儿童配方奶粉及其制备方法
CN113068747A (zh) * 2020-03-24 2021-07-06 北京三元食品股份有限公司 一种促进孕产妇和婴幼儿健康的孕产妇配方乳粉

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4762822A (en) 1985-08-08 1988-08-09 Ettinger Anna C Reduction of gastrointestinal disease-producing organisms with sialic acid and gangliosides
DD273543A3 (de) 1987-09-14 1989-11-22 Univ Rostock Verfahren zur herstellung von saeuglings- und diaetnahrungen mit hypoantigener, bifidogener wirkung
ES2053627T3 (es) 1988-07-07 1994-08-01 Milupa Ag Procedimiento para la preparacion de un alimento bifidogeno dietetico y para lactantes.
US6020015A (en) 1988-09-22 2000-02-01 Gaull; Gerald E. Infant formula compositions and nutrition containing genetically engineered human milk proteins
US5180674A (en) 1990-04-16 1993-01-19 The Trustees Of The University Of Pennsylvania Saccharide compositions, methods and apparatus for their synthesis
CH681543A5 (pl) * 1990-04-27 1993-04-15 Nestle Sa
JP3035833B2 (ja) 1991-01-21 2000-04-24 雪印乳業株式会社 シアル酸類含有組成物の製造方法
JP3125451B2 (ja) * 1991-11-05 2001-01-15 ソニー株式会社 信号処理方法
JPH07277929A (ja) 1994-04-01 1995-10-24 Momotani Jiyuntenkan:Kk 育毛、養毛料
US5576300A (en) 1994-09-16 1996-11-19 Abbott Laboratories Method for inhibition of human rotavirus infection
US5575916A (en) 1994-11-07 1996-11-19 Neose Pharmaceuticals, Inc. Method of processing a cheese processing waste stream
US5849324A (en) 1995-07-10 1998-12-15 Abbott Laboratories Use of indigestible oligosaccharides to reduce the incidence of otitis media in humans
WO1998008402A1 (en) 1996-08-30 1998-03-05 Societe Des Produits Nestle S.A. Nutritional formula for phenylketonuria patients
DE69718455T2 (de) * 1997-07-22 2003-04-30 Societe Des Produits Nestle S.A., Vevey Lipidzusammensetzung für Säuglingsnährpräparat und Herstellungsverfahren
US6168823B1 (en) 1997-10-09 2001-01-02 Wisconsin Alumni Research Foundation Production of substantially pure kappa casein macropeptide
ATE303077T1 (de) 1999-04-29 2005-09-15 Nestle Sa Süssmolkeprotein enthaltende säuglingsnahrung
US6288222B1 (en) 2000-02-16 2001-09-11 Neose Technologies, Inc. Method of filtration of a dairy stream
AU2001238285A1 (en) 2000-02-17 2001-08-27 Wyeth Nutritional formulation containing prebiotic substances
US20020044988A1 (en) 2000-08-22 2002-04-18 Fuchs Eileen C. Nutritional composition and method for improving protein deposition
GB0116509D0 (en) 2001-07-06 2001-08-29 Hannah Res Inst The Methods of extracting casein fractions from milk and caseinates and production of novel products

Also Published As

Publication number Publication date
BRPI0409309A (pt) 2006-04-18
CN1802094A (zh) 2006-07-12
WO2004093557A1 (en) 2004-11-04
TW200503631A (en) 2005-02-01
NO20055335L (no) 2006-01-03
TWI369183B (en) 2012-08-01
DK1613169T3 (da) 2010-09-20
HK1091376A1 (zh) 2007-01-19
RU2005135122A (ru) 2006-03-10
NO20055335D0 (no) 2005-11-11
US7867541B2 (en) 2011-01-11
CA2522091A1 (en) 2004-11-04
PT1613169E (pt) 2010-06-17
MY154371A (en) 2015-06-15
EP1613169A1 (en) 2006-01-11
CN100515216C (zh) 2009-07-22
ES2346533T3 (es) 2010-10-18
ECSP056101A (es) 2006-03-01
KR101087332B1 (ko) 2011-11-25
CL2004000803A1 (es) 2005-05-06
EP1613169B1 (en) 2010-06-02
RU2361408C2 (ru) 2009-07-20
ATE469560T1 (de) 2010-06-15
BRPI0409309B1 (pt) 2020-09-15
US20040202765A1 (en) 2004-10-14
AR043846A1 (es) 2005-08-17
DE602004027476D1 (de) 2010-07-15
MXPA05010806A (es) 2005-12-05
KR20060006921A (ko) 2006-01-20
NO330441B1 (no) 2011-04-11
CA2522091C (en) 2011-10-11

Similar Documents

Publication Publication Date Title
TWI369183B (en) Compositions and methods of formulation for enteral formulas containing sialic acid
PL1811868T3 (pl) Kompozycje i sposoby formułowania mieszanek dojelitowych zawierających kwas sialowy
EP1610742A4 (en) METHODS AND COMPOSITIONS FOR ADMINISTERING TRPV1 AGONISTS
IL166108A0 (en) Novel compounds pharmaceutical compositions containing same and methods of use for same
SI2181988T1 (sl) Farmacevtski sestavki, na osnovi kristalinične oblike I 5-azacitidina
HUP0500173A3 (en) Alpha-sulphonamido-acetamide derivatives as beta-amyloid inhibitors and pharmaceutical compositions containing them
IL172776A (en) Derivatives of esters of 3-oxo-10 ß-hydroxy-17 ß-cyanomethyl (oxo / theo) carbonyl – androsta – 4,1 – dian – 17 α– carboxylic acid and pharmaceutical preparations containing them
IL179250A0 (en) Stable crystal of 4-oxoquinoline compound and pharmaceutical compositions containing the same
IL178128A0 (en) Salts of 3-0-(3',3'-dimethyl-succinyl) betulinic acid and pharmaceutical compositions containing the same
AU2003251557A1 (en) Fat compositions for infant formula and methods therefor
IL164217A0 (en) Pharmaceutical compositions containing water-soluble propofol and methods of administering same
HUP0401693A3 (en) Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, their preparation an use and pharmaceutical compositions containing such derivatives
PL1601363T3 (pl) Zastosowanie pochodnych cholest-4-en-onu jako leków, kompozycje farmaceutyczne zawierające te pochodne, nowe pochodne i sposób ich wytwarzania
IL166054A0 (en) Novel compounds pharmaceutical compositions containing same and methods of use for same
IL163959A (en) Derivatives of phenyl-sulfonylamino- benzoic acid and pharmaceutical compositions comprising them
IL170316A (en) Cycloalkyl-methoxy substituted acetic acid derivatives and pharmaceutical compositions comprising them
IL174507A0 (en) Pharmaceutical compositions comprising malonamide derivatives for decreasing sebum production
ZA200600315B (en) Compositions for purifying and crystallizing molecules of interest
IL174248A0 (en) Alkyl carboxylic acid derivatives and pharmaceutical compositions containing the same
IL176077A0 (en) 1-n-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them
EG24668A (en) Cyclic amine derivatives processes for their preparation and pharmaceutical compositions containing them
IL157849A0 (en) Pharmaceutical compositions containing (+) cannabidiol and derivatives thereof and some such novel derivatives
IL172758A0 (en) Pharmaceutical compositions containing balaglitazone and methods for the preparation thereof
IL169312A0 (en) Cetylpyridinium salt of an anti-inflammatory agent and pharmaceutical compositions containing it
GB2404856B (en) Stable pharmaceutical composition of rabeprazole